Ariad Pharmaceuticals Inc fka ARIA

[floWteiuQ]

CML developments:

http://medicalxpress.com/news/2016-06-scientists-drugs-achilles-heel-chronic.html

At the bottom of the article:

"Current therapy for CML is with tyrosine kinase inhibitors (TKIs) which effectively hold back the disease, but do not cure it. If the therapy is stopped, the leukaemia relapses in the majority of patients, requiring CML patients to remain on treatment for their lifetime. These drugs, as well as being costly to administer, can cause a number of side effects including diabetes and vascular problems. It is the dual issues of cost and toxicity in current CML treatment that has driven this particular piece of research."